BioCentury
ARTICLE | Financial News

Myovant amends IPO

October 24, 2016 7:00 AM UTC

Myovant Sciences Ltd., Hamilton, BermudaBusiness: Genitourinary, Cancer, Endocrine/MetabolicDate announced: 2016-10-17Type: IPOTo be raised: Up to $195 millionShares: 13 millionPrice: $12-$15Underwrit...